TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -11.60%2.06B | 0.29%4.9B | 1.31%2.33B | -9.34%4.88B | -10.41%2.3B | 18.48%5.39B | 29.41%2.57B | -18.58%4.55B | -21.19%1.98B | -29.45%5.58B |
Operating income | -11.60%2.06B | 0.29%4.9B | 1.31%2.33B | -9.34%4.88B | -10.41%2.3B | 18.48%5.39B | 29.41%2.57B | -18.58%4.55B | -21.19%1.98B | -29.45%5.58B |
Cost of sales | 43.40%-296M | 14.70%-1.34B | 27.66%-523M | 24.54%-1.57B | 20.64%-723M | -68.17%-2.08B | -189.21%-911M | 36.22%-1.24B | 56.49%-315M | 53.80%-1.94B |
Operating expenses | 43.40%-296M | 14.70%-1.34B | 27.66%-523M | 24.54%-1.57B | 20.64%-723M | -68.17%-2.08B | -189.21%-911M | 36.22%-1.24B | 56.49%-315M | 53.80%-1.94B |
Gross profit | -2.38%1.76B | 7.40%3.56B | 14.60%1.81B | 0.24%3.31B | -4.78%1.58B | -0.12%3.3B | -0.78%1.65B | -9.17%3.31B | -6.92%1.67B | -1.89%3.64B |
Employee expense | -11.43%-195M | -9.52%-368M | -4.79%-175M | -11.63%-336M | -4.38%-167M | 4.75%-301M | 3.03%-160M | 15.96%-316M | 14.95%-165M | -0.53%-376M |
Depreciation and amortization | 0.27%-737M | -1.72%-1.48B | -3.36%-739M | -12.00%-1.46B | -13.13%-715M | -6.21%-1.3B | -3.95%-632M | -1.41%-1.22B | -0.83%-608M | -57.16%-1.21B |
Special items of operating profit | 7.17%-867M | -11.16%-1.79B | -26.05%-934M | -1.96%-1.61B | 4.51%-741M | -14.55%-1.58B | -2.51%-776M | 17.40%-1.38B | 10.41%-757M | 25.79%-1.67B |
Operating profit | 13.95%-37M | 8.51%-86M | 10.42%-43M | -178.33%-94M | -155.81%-48M | -68.91%120M | -37.23%86M | 0.00%386M | -8.05%137M | 22.15%386M |
Financing income | 8.79%99M | 196.97%196M | 506.67%91M | 175.00%66M | 15.38%15M | -76.92%24M | -81.94%13M | -44.68%104M | -33.94%72M | -12.15%188M |
Financing cost | -7.89%-41M | -3.90%-80M | 0.00%-38M | -42.59%-77M | -65.22%-38M | -28.57%-54M | -15.00%-23M | -20.00%-42M | -17.65%-20M | -66.67%-35M |
Share of profit from joint venture company | 0.00%-2M | 0.00%-4M | 0.00%-2M | 0.00%-4M | 0.00%-2M | 0.00%-4M | 0.00%-2M | 0.00%-4M | 0.00%-2M | 0.00%-4M |
Earning before tax | 137.50%19M | 123.85%26M | 110.96%8M | -226.74%-109M | -198.65%-73M | -80.63%86M | -60.43%74M | -17.01%444M | -21.76%187M | 5.94%535M |
Tax | -14.81%-31M | -59.18%-78M | -17.39%-27M | 40.24%-49M | 46.51%-23M | 1.20%-82M | -4.88%-43M | 15.31%-83M | 4.65%-41M | -36.11%-98M |
After-tax profit from continuing operations | 36.84%-12M | 67.09%-52M | 80.21%-19M | -4,050.00%-158M | -409.68%-96M | -98.89%4M | -78.77%31M | -17.39%361M | -25.51%146M | 0.92%437M |
Earning after tax | 36.84%-12M | 67.09%-52M | 80.21%-19M | -4,050.00%-158M | -409.68%-96M | -98.89%4M | -78.77%31M | -17.39%361M | -25.51%146M | 0.92%437M |
Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -72.41%8M |
Profit attributable to shareholders | 36.84%-12M | 67.09%-52M | 80.21%-19M | -4,050.00%-158M | -409.68%-96M | -98.89%4M | -78.77%31M | -15.85%361M | -22.34%146M | 6.19%429M |
Basic earnings per share | 35.90%-0.0025 | 67.07%-0.0108 | 80.40%-0.0039 | -4,200.00%-0.0328 | -410.94%-0.0199 | -98.93%0.0008 | -78.88%0.0064 | -15.84%0.0749 | -22.31%0.0303 | 6.21%0.089 |
Diluted earnings per share | 35.90%-0.0025 | 67.07%-0.0108 | 80.40%-0.0039 | -4,200.00%-0.0328 | -410.94%-0.0199 | -98.93%0.0008 | -78.88%0.0064 | -15.84%0.0749 | -22.31%0.0303 | 6.21%0.089 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.